(WHTM) — A global campaign is marking Brain Awareness Week through Sunday, and Penn State professors are explaining some of ...

New findings suggest that targeting inflammation in Alzheimer’s may matter as much as targeting protein buildup.

Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

After identifying that accumulation of toxic tau and amyloid proteins in the brain are a feature of Alzheimer’s disease, researchers have, understandably, been working on treatments that reduce or ...

Researchers are engineering a new class of miniature antibodies, called intrabodies, that can operate inside living cells to ...

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

A new study found that women who test positive for A Parkinson-s related protein accumulated tau at a much faster rate, ...

Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...

HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s ...